000 | 02866pam a22003611i 4500 | ||
---|---|---|---|
001 | i9780323879323 | ||
003 | Uk | ||
005 | 20240227124826.0 | ||
006 | m || d | | ||
007 | cr ||||||||||| | ||
008 | 221128s2022 ne o 000|0|eng|d | ||
015 |
_aGBC2L5046 _2bnb |
||
020 |
_a9780323879330 _c£65.99 |
||
020 | _a9780323879323 | ||
037 |
_a9780323879330 _bIngram Content Group |
||
040 |
_aStDuBDS _beng _cStDuBDS _dUk _erda _epn |
||
042 | _aukblsr | ||
082 | 0 | 4 |
_a618.11 _223 |
099 | _aWP 654 | ||
245 | 0 | 0 |
_aPolycystic ovary syndrome : _bbasic science to clinical advances across the lifespan / _cedited by Rehana Rehman, Aisha Sheikh. |
264 | 1 |
_aAmsterdam : _bElsevier, _c2022. |
|
300 | _bPBK | ||
505 | 0 | _a<p>SECTION I: Overview of PCOS</p> <p>Chapter 1 Introduction to Polycystic Ovary Syndrome (PCOS)</p> <p>Chapter 2 Classification of PCOS </p> <p>Chapter 3 PCOS Phenotypes </p> <p>Chapter 4 PCOS in Adolescents </p> <b> <p>SECTION II: Pathogenesis and Clinical Presentation</p></b> <p>Chapter 5 Pathophysiology of PCOS</p> <p>Chapter 6 Interplay of Adipocytokines with PCOS </p> <p>Chapter 7 Role of Oxidative Stress and Chronic Inflammation in Pathogenesis of PCOS </p> <p>Chapter 8 PCOS and Subfertility: Ovulation Dysregulation, Fertility problems</p> <p>Chapter 9 Clinical Features/Presentation of PCOS</p> <p>Chapter 10 Diagnostic Criteria for PCOS</p> <p>Chapter 11 PCOS & Metabolic Syndrome & Risks in Later Life </p> <p>Chapter 12 PCOS and Mental Health</p> <p>Chapter 13 PCOS and Liver Diseases </p> <p>Chapter 14 Male PCOS Equivalent </p> <b> <p>SECTION III: Management of PCOS & Associated Co-Morbidities</p></b> <p>Chapter 15 Pharmacological Management Menstrual Irregularities</p> <p>Chapter 16 Pharmacological Management of Hirsutism and Acne</p> <p>Chapter 17 Pharmacological Management for Weight Management</p> <p>Chapter 18 Role of Insulin Sensitizers in Management of PCOS </p> <p>Chapter 19 Cardiovascular Risk Reduction in PCOS </p> <p>Chapter 20 Management for Subfertility </p> <p>Chapter 21 Management of Associated Risks of Pregnancy in PCOS </p> <p>Chapter 22 Importance of Life-Style Modifications </p> <p>Chapter 23 Role of Complementary-Alternative Medicine </p> <p>Chapter 24 Evidence Based Recommendations for Clinical Practice (Future Directions: Research and Practice) </p> <b> <p>SECTION IV: Global Approach to PCOS</p></b> <p>Chapter 25 South Asia</p> <p>Chapter 26 Rest of Asia</p> <p>Chapter 27 Europe </p> <p>Chapter 28 Africa </p> <p>Chapter 29 North America </p> | |
650 | 4 |
_aPolycystic Ovary Syndrome _95319 |
|
650 | 4 |
_aGynaecology _92864 |
|
700 |
_aRehman, Rehana _eeditor. |
||
700 | 1 |
_aSheikh, Aisha, _eeditor. |
|
903 | _aELD.DS.737326 | ||
942 | _cBKSTD | ||
998 |
_c144922 _d144922 |
||
999 |
_c60919 _d60919 |